Cellply

📍 Bologna, Italy🗓 Founded 2013👥 23 employees💰 Last funded Nov 2021
Biotechnology Research🌐 cellply.com
Website LinkedIn
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Cellply?
Cellply has 1 investors on record on gritt.io and 1 late-stage investors.
When did Cellply last raise funding?
The most recent investment in Cellply recorded on gritt.io was in November 2021.
When was Cellply founded?
Cellply was founded in 2013.
What industry is Cellply in?
Cellply operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cellply based?
Cellply is headquartered in Bologna, Italy.